Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
Version 3 2025-09-09, 04:27
Version 2 2024-06-05, 04:22
Version 1 2020-12-01, 00:00
journal contribution
posted on 2025-09-09, 04:27 authored by G Morris, Eugene AthanEugene Athan, Ken WalderKen Walder, Chiara BortolasciChiara Bortolasci, Adrienne O'NeilAdrienne O'Neil, Wolf MarxWolf Marx, Michael BerkMichael Berk, AF Carvalho, M Maes, BK PuriCan endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
History
Related Materials
- 1.
Location
NetherlandsOpen access
- Yes
Link to full text
Language
EnglishPublication classification
C1 Refereed article in a scholarly journalJournal
Life SciencesVolume
262Article number
ARTN 118541Pagination
1 - 14ISSN
0024-3205eISSN
1879-0631Publisher
PERGAMON-ELSEVIER SCIENCE LTDUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalPharmacology & PharmacyResearch & Experimental MedicineAntiviral treatmentCOVID-19SARS-CoV-2ImmunomodulationMacrolideRESPIRATORY SYNDROME CORONAVIRUSSYSTEMIC-LUPUS-ERYTHEMATOSUSOBSTRUCTIVE PULMONARY-DISEASEPRO-INFLAMMATORY CYTOKINESHIV-INFECTED PATIENTSELEVATED GOLGI PHRHEUMATOID-ARTHRITISENDOPLASMIC-RETICULUMVIRAL LOADKAPPA-B110999 Neurosciences not elsewhere classifiedFaculty of HealthSchool of MedicineInstitute for Innovation in Mental and Physical Health and Clinical Translation3209 Neurosciences3204 Immunology420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC